This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lebrun, J. J.
Right arrow Articles by Vale, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lebrun, J. J.
Right arrow Articles by Vale, W. W.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Mar 1997, 1682-1691, Vol 17, No. 3
Copyright © 1997, American Society for Microbiology

Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation

JJ Lebrun and WW Vale
The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.

Activins and inhibins belong to the transforming growth factor beta (TGF-beta)-like superfamily and exert their effects on a broad range of cellular targets by modulating cell differentiation and proliferation. Members of this family interact with two structurally related classes of receptors (type I and type II), both containing a serine/threonine kinase domain. When expressed alone, the type II but not the type I activin receptor can bind activin. However, the presence of a type I receptor is required for signaling. For TGF-beta1, ligand binding to the type II receptor results in the recruitment and transphosphorylation of the type I receptor. Transient overexpression of the two types of activin receptor results in ligand-independent receptor heteromerization and activation. Nevertheless, activin addition to the transfected cells increased complex formation between the two receptors, suggesting a mechanism of action similar to that observed for the TGF-beta receptor. In the present study, we generated a stable cell line, overexpressing the two types of activin receptor upon induction, in the human erythroleukemia cell line K562. We demonstrate here that activin specifically induces heteromer formation between the type I and type II receptors in a time-dependent manner. Using this stable line, we analyzed the effects of activin and inhibin on human erythroid differentiation. Our results indicate that activin signal transduction mediated through its type I and type II receptors results in an increase in the hemoglobin content of the cells and limits their proliferation. Finally, using cell lines that can be induced to overexpress ActRII and ActRIB or ActRIB only, we show that the inhibin antagonistic effects on activin-induced biological responses are mediated through a competition for the type II activin receptor but also require the presence of an inhibin-specific binding component.


This article has been cited by other articles:

  • Lamba, P., Fortin, J., Tran, S., Wang, Y., Bernard, D. J. (2009). A Novel Role for the Forkhead Transcription Factor FOXL2 in Activin A-Regulated Follicle-Stimulating Hormone {beta} Subunit Transcription. Mol. Endocrinol. 23: 1001-1013 [Abstract] [Full Text]  
  • Wiater, E., Lewis, K. A., Donaldson, C., Vaughan, J., Bilezikjian, L., Vale, W. (2009). Endogenous Betaglycan Is Essential for High-Potency Inhibin Antagonism in Gonadotropes. Mol. Endocrinol. 23: 1033-1042 [Abstract] [Full Text]  
  • Ferreira, M.C., Witz, C.A., Hammes, L.S., Kirma, N., Petraglia, F., Schenken, R.S., Reis, F.M. (2008). Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum. Mol Hum Reprod 14: 301-307 [Abstract] [Full Text]  
  • Veiga-Lopez, A., Ye, W., Phillips, D.J., Herkimer, C., Knight, P.G., Padmanabhan, V. (2008). Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep. Biol. Reprod. 78: 636-647 [Abstract] [Full Text]  
  • Korupolu, R. V., Muenster, U., Read, J. D., Vale, W., Fischer, W. H. (2008). Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-like Activity and Antagonize Activin and Myostatin. J. Biol. Chem. 283: 3782-3790 [Abstract] [Full Text]  
  • Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X.-L., Han, J.-D. J., Chen, Y.-G. (2008). MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111: 588-595 [Abstract] [Full Text]  
  • Looyenga, B. D., Hammer, G. D. (2007). Genetic Removal of Smad3 from Inhibin-Null Mice Attenuates Tumor Progression by Uncoupling Extracellular Mitogenic Signals from the Cell Cycle Machinery. Mol. Endocrinol. 21: 2440-2457 [Abstract] [Full Text]  
  • Hempel, N., How, T., Dong, M., Murphy, S. K., Fields, T. A., Blobe, G. C. (2007). Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion. Cancer Res. 67: 5231-5238 [Abstract] [Full Text]  
  • Kipp, J. L., Kilen, S. M., Bristol-Gould, S., Woodruff, T. K., Mayo, K. E. (2007). Neonatal Exposure to Estrogens Suppresses Activin Expression and Signaling in the Mouse Ovary. Endocrinology 148: 1968-1976 [Abstract] [Full Text]  
  • Lee, K. B, Khivansara, V., Santos, M. M, Lamba, P., Yuen, T., Sealfon, S. C, Bernard, D. J (2007). Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone {beta} subunit transcription. J Mol Endocrinol 38: 315-330 [Abstract] [Full Text]  
  • Farnworth, P. G., Stanton, P. G., Wang, Y., Escalona, R., Findlay, J. K., Ooi, G. T. (2006). Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line. Endocrinology 147: 3462-3471 [Abstract] [Full Text]  
  • Muenster, U., Harrison, C. A., Donaldson, C., Vale, W., Fischer, W. H. (2005). An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties. J. Biol. Chem. 280: 36626-36632 [Abstract] [Full Text]  
  • Omori, Y., Nakamura, K., Yamashita, S., Matsuda, H., Mizutani, T., Miyamoto, K., Minegishi, T. (2005). Effect of Follicle-Stimulating Hormone and Estrogen on the Expression of Betaglycan Messenger Ribonucleic Acid Levels in Cultured Rat Granulosa Cells. Endocrinology 146: 3379-3386 [Abstract] [Full Text]  
  • Luisi, S., Florio, P., Reis, F. M., Petraglia, F. (2005). Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. Hum Reprod Update 11: 123-135 [Abstract] [Full Text]  
  • Florio, P., Ciarmela, P., Reis, F. M, Toti, P., Galleri, L., Santopietro, R., Tiso, E, Tosi, P., Petraglia, F. (2005). Inhibin {alpha}-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma. Eur J Endocrinol 152: 277-284 [Abstract] [Full Text]  
  • Foster, C. M., Olton, P. R., Padmanabhan, V. (2005). Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls. Hum Reprod 20: 543-548 [Abstract] [Full Text]  
  • Steller, M. D., Shaw, T. J., Vanderhyden, B. C., Ethier, J.-F. (2005). Inhibin Resistance Is Associated with Aggressive Tumorigenicity of Ovarian Cancer Cells. Mol Cancer Res 3: 50-61 [Abstract] [Full Text]  
  • Dixit, H., Deendayal, M., Singh, L. (2004). Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 19: 1760-1764 [Abstract] [Full Text]  
  • Harrison, C. A., Gray, P. C., Fischer, W. H., Donaldson, C., Choe, S., Vale, W. (2004). An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors. J. Biol. Chem. 279: 28036-28044 [Abstract] [Full Text]  
  • Lacerte, A., Lee, E.-H., Reynaud, R., Canaff, L., de Guise, C., Devost, D., Ali, S., Hendy, G. N., Lebrun, J.-J. (2004). Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin. Mol. Endocrinol. 18: 1558-1569 [Abstract] [Full Text]  
  • Shimasaki, S., Moore, R. K., Otsuka, F., Erickson, G. F. (2004). The Bone Morphogenetic Protein System In Mammalian Reproduction. Endocr. Rev. 25: 72-101 [Abstract] [Full Text]  
  • Prendergast, K. A., Burger, L. L., Aylor, K. W., Haisenleder, D. J., Dalkin, A. C., Marshall, J. C. (2004). Pituitary Follistatin Gene Expression in Female Rats: Evidence That Inhibin Regulates Transcription. Biol. Reprod. 70: 364-370 [Abstract] [Full Text]  
  • Chapman, S. C., Woodruff, T. K. (2003). Betaglycan Localization in the Female Rat Pituitary: Implications for the Regulation of Follicle-Stimulating Hormone by Inhibin. Endocrinology 144: 5640-5649 [Abstract] [Full Text]  
  • Bernard, D. J., Burns, K. H., Haupt, B., Matzuk, M. M., Woodruff, T. K. (2003). Normal Reproductive Function in InhBP/p120-Deficient Mice. Mol. Cell. Biol. 23: 4882-4891 [Abstract] [Full Text]  
  • Jeruss, J. S., Sturgis, C. D., Rademaker, A. W., Woodruff, T. K. (2003). Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer. Cancer Res. 63: 3783-3790 [Abstract] [Full Text]  
  • Wiater, E., Vale, W. (2003). Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling. J. Biol. Chem. 278: 7934-7941 [Abstract] [Full Text]  
  • Ethier, J.-F., Farnworth, P. G., Findlay, J. K., Ooi, G. T. (2002). Transforming Growth Factor-{beta} Modulates Inhibin A Bioactivity in the L{beta}T2 Gonadotrope Cell Line by Competing for Binding to Betaglycan. Mol. Endocrinol. 16: 2754-2763 [Abstract] [Full Text]  
  • Hayes, S., Chawla, A., Corvera, S. (2002). TGF{beta} receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. JCB 158: 1239-1249 [Abstract] [Full Text]  
  • Bernard, D. J., Chapman, S. C., Woodruff, T. K. (2002). Minireview: Inhibin Binding Protein (InhBP/p120), Betaglycan, and the Continuing Search for the Inhibin Receptor. Mol. Endocrinol. 16: 207-212 [Abstract] [Full Text]  
  • Chen, Y.-G., Lui, H. M., Lin, S.-L., Lee, J. M., Ying, S.-Y. (2002). Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin. Exp. Biol. Med. 227: 75-87 [Abstract] [Full Text]  
  • Plant, T. M., Marshall, G. R. (2001). The Functional Significance of FSH in Spermatogenesis and the Control of Its Secretion in Male Primates. Endocr. Rev. 22: 764-786 [Abstract] [Full Text]  
  • Bernard, D. J., Woodruff, T. K. (2001). Inhibin Binding Protein in Rats: Alternative Transcripts and Regulation in the Pituitary across the Estrous Cycle. Mol. Endocrinol. 15: 654-667 [Abstract] [Full Text]  
  • Chapman, S. C., Woodruff, T. K. (2001). Modulation of Activin Signal Transduction by Inhibin B and Inhibin-Binding Protein (InhBP). Mol. Endocrinol. 15: 668-679 [Abstract] [Full Text]  
  • Harrison, C. A., Farnworth, P. G., Chan, K. L., Stanton, P. G., Ooi, G. T., Findlay, J. K., Robertson, D. M. (2001). Identification of Specific Inhibin A-Binding Proteins on Mouse Leydig (TM3) and Sertoli (TM4) Cell Lines. Endocrinology 142: 1393-1402 [Abstract] [Full Text]  
  • Bilezikjian, L. M., Corrigan, A. Z., Blount, A. L., Chen, Y., Vale, W. W. (2001). Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-{{beta}} Signaling in Anterior Pituitary Cells. Endocrinology 142: 1065-1072 [Abstract] [Full Text]  
  • Zhou, Y., Sun, H., Danila, D. C., Johnson, S. R., Sigai, D. P., Zhang, X., Klibanski, A. (2000). Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling. Mol. Endocrinol. 14: 2066-2075 [Abstract] [Full Text]  
  • Pierson, T. M., Wang, Y., DeMayo, F. J., Matzuk, M. M., Tsai, S. Y., O’Malley, B. W. (2000). Regulable Expression of Inhibin A in Wild-Type and Inhibin {alpha} Null Mice. Mol. Endocrinol. 14: 1075-1085 [Abstract] [Full Text]  
  • Matzuk, M. M. (2000). Editorial: In Search of Binding--Identification of Inhibin Receptors. Endocrinology 141: 2281-2284 [Full Text]  
  • Chong, H., Pangas, S. A., Bernard, D. J., Wang, E., Gitch, J., Chen, W., Draper, L. B., Cox, E. T., Woodruff, T. K. (2000). Structure and Expression of a Membrane Component of the Inhibin Receptor System. Endocrinology 141: 2600-2607 [Abstract] [Full Text]  
  • Kitamura, K., Aota, S.-i., Sakamoto, R., Yoshikawa, S.-I., Okazaki, K. (2000). Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation. Blood 95: 3371-3379 [Abstract] [Full Text]  
  • Ezal, C. H., Marion, C. D., Smith, W. C. (2000). Primary Structure Requirements for Xenopus Nodal-related 3 and a Comparison with Regions Required by Xenopus Nodal-related 2. J. Biol. Chem. 275: 14124-14131 [Abstract] [Full Text]  
  • Gray, P. C., Greenwald, J., Blount, A. L., Kunitake, K. S., Donaldson, C. J., Choe, S., Vale, W. (2000). Identification of a Binding Site on the Type II Activin Receptor for Activin and Inhibin. J. Biol. Chem. 275: 3206-3212 [Abstract] [Full Text]  
  • Miyazono, K (2000). Positive and negative regulation of TGF-beta signaling. J. Cell Sci. 113: 1101-1109 [Abstract]  
  • PIEK, E., HELDIN, C.-H., TEN DIJKE, P. (1999). Specificity, diversity, and regulation in TGF-{beta} superfamily signaling. FASEB J. 13: 2105-2124 [Abstract] [Full Text]  
  • Pang, Y., Ge, W. (1999). Activin Stimulation of Zebrafish Oocyte Maturation in Vitro and Its Potential Role in Mediating Gonadotropin-Induced Oocyte Maturation. Biol. Reprod. 61: 987-992 [Abstract] [Full Text]  
  • Delbaere, A., Sidis, Y., Schneyer, A. L. (1999). Differential Response to Exogenous and Endogenous Activin in a Human Ovarian Teratocarcinoma-Derived Cell Line (PA-1): Regulation by Cell Surface Follistatin. Endocrinology 140: 2463-2470 [Abstract] [Full Text]  
  • Lux, A., Attisano, L., Marchuk, D. A. (1999). Assignment of Transforming Growth Factor beta 1 and beta 3 and a Third New Ligand to the Type I Receptor ALK-1. J. Biol. Chem. 274: 9984-9992 [Abstract] [Full Text]  
  • Woodruff, T. K. (1999). Editorial: Hope, Hypothesis, and the Inhibin Receptor. Does Specific Inhibin Binding Suggest There Is a Specific Inhibin Receptor?. Endocrinology 140: 3-5 [Full Text]  
  • Hertan, R., Farnworth, P. G., Fitzsimmons, K. L., Robertson, D. M. (1999). Identification of High Affinity Binding Sites for Inhibin on Ovine Pituitary Cells in Culture. Endocrinology 140: 6-12 [Abstract] [Full Text]  
  • Lebrun, J.-J., Takabe, K., Chen, Y., Vale, W. (1999). Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling. Mol. Endocrinol. 13: 15-23 [Abstract] [Full Text]  
  • Sidis,, Y., Fujiwara,, T., Leykin,, L., Isaacson,, K., Toth,, T., Schneyer, A. L. (1998). Characterization of Inhibin/Activin Subunit, Activin Receptor, and Follistatin Messenger Ribonucleic Acid in Human and Mouse Oocytes: Evidence for Activin's Paracrine Signaling from Granulosa Cells to Oocytes. Biol. Reprod. 59: 807-812 [Abstract] [Full Text]  
  • Draper, L. B., Matzuk, M. M., Roberts, V. J., Cox, E., Weiss, J., Mather, J. P., Woodruff, T. K. (1998). Identification of an Inhibin Receptor in Gonadal Tumors from Inhibin alpha -Subunit Knockout Mice. J. Biol. Chem. 273: 398-403 [Abstract] [Full Text]  
  • Lam, L. T., Ronchini, C., Norton, J., Capobianco, A. J., Bresnick, E. H. (2000). Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1. J. Biol. Chem. 275: 19676-19684 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»